ES2644138T3 - N,N,N-trialquilpolímeros, métodos para su preparación y usos de los mismos - Google Patents

N,N,N-trialquilpolímeros, métodos para su preparación y usos de los mismos Download PDF

Info

Publication number
ES2644138T3
ES2644138T3 ES12800482.7T ES12800482T ES2644138T3 ES 2644138 T3 ES2644138 T3 ES 2644138T3 ES 12800482 T ES12800482 T ES 12800482T ES 2644138 T3 ES2644138 T3 ES 2644138T3
Authority
ES
Spain
Prior art keywords
tmc
trimethylchitosan
approximately
chitosan
less
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES12800482.7T
Other languages
English (en)
Spanish (es)
Inventor
Jonathan Gagnon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rival SC
Original Assignee
Rival SC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rival SC filed Critical Rival SC
Application granted granted Critical
Publication of ES2644138T3 publication Critical patent/ES2644138T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/736—Chitin; Chitosan; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • C08B37/0027—2-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
    • C08B37/003—Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Birds (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
ES12800482.7T 2011-06-13 2012-06-13 N,N,N-trialquilpolímeros, métodos para su preparación y usos de los mismos Active ES2644138T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161496225P 2011-06-13 2011-06-13
US201161496225P 2011-06-13
PCT/CA2012/050399 WO2012171125A1 (en) 2011-06-13 2012-06-13 N,n,n-trialkylpolymers, methods of their preparation and uses thereof

Publications (1)

Publication Number Publication Date
ES2644138T3 true ES2644138T3 (es) 2017-11-27

Family

ID=47356469

Family Applications (1)

Application Number Title Priority Date Filing Date
ES12800482.7T Active ES2644138T3 (es) 2011-06-13 2012-06-13 N,N,N-trialquilpolímeros, métodos para su preparación y usos de los mismos

Country Status (6)

Country Link
US (1) US9505852B2 (enExample)
EP (1) EP2718331B1 (enExample)
JP (2) JP6346561B2 (enExample)
CA (1) CA2869821C (enExample)
ES (1) ES2644138T3 (enExample)
WO (1) WO2012171125A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2718331B1 (en) * 2011-06-13 2017-08-02 Rival S.E.C N,n,n-trialkylpolymers, methods of their preparation and uses thereof
WO2015022907A1 (ja) * 2013-08-13 2015-02-19 生化学工業株式会社 カチオン化キトサンを含有する医薬
CN106132978A (zh) * 2014-02-19 2016-11-16 波兰科学院生物化学与生物物理研究所 一种生物聚合物衍生物的合成方法,该生物聚合物衍生物及其用途
CN106167532B (zh) * 2016-09-27 2018-10-26 江南大学 一种壳聚糖季铵盐的制备方法
CN107163165B (zh) * 2017-06-14 2020-01-31 山东师范大学 一种o-羧甲基-n,n-双链长烷基化壳寡糖及制备方法与应用
WO2019169478A1 (en) * 2018-03-05 2019-09-12 Ovensa Inc. Treatment of protein aggregation diseases using n,n,n-trimethylchitosan
WO2020039463A1 (en) 2018-08-23 2020-02-27 Haskoli Islands Chitosan derivatives and methods for preparing the same
JP7365279B2 (ja) * 2020-03-25 2023-10-19 大日精化工業株式会社 キトサン誘導体の製造方法
JP2021172727A (ja) * 2020-04-24 2021-11-01 大日精化工業株式会社 キトサン誘導体及びその製造方法、ｏ／ｗ型乳化組成物、並びに化粧料
KR102570766B1 (ko) * 2020-12-04 2023-08-24 단국대학교 천안캠퍼스 산학협력단 N,n,n-트리메틸 키토산을 포함하는 스프레이 조성물
CN112651384B (zh) * 2021-01-15 2022-08-16 芜湖美的厨卫电器制造有限公司 用于零冷水燃气热水器的方法、装置、存储介质及处理器
WO2024259525A1 (en) * 2023-06-19 2024-12-26 Societe De Commercialisation Des Produits De La Recherche Appliquee Socpra Sante Et Humaines, S.E.C. Nanoparticles comprising n,n,n-trimethyl chitosan coated with peptide agonists of kinin b1 or b2 and/or peptide antagonists of kinin b1 for transvascular drug delivery across the blood-brain barrier

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5744166A (en) 1989-02-25 1998-04-28 Danbiosyst Uk Limited Drug delivery compositions
US6410046B1 (en) 1996-11-19 2002-06-25 Intrabrain International Nv Administering pharmaceuticals to the mammalian central nervous system
GB9710699D0 (en) 1997-05-24 1997-07-16 Danbiosyst Uk Gastro-retentive controlled release system
US6328967B1 (en) 1998-03-12 2001-12-11 Allergenics, Inc. Delivery system to modulate immune response
EP1035137A1 (en) 1999-03-12 2000-09-13 Pasteur Merieux Serums Et Vaccins Method for the reductive amination of polysaccharides
FR2804317B1 (fr) 2000-01-28 2008-06-13 Rhodia Chimie Sa Compositions cosmetiques comprenant un melange polymere cationique/tensioactif et utilisation dudit melange comme agent structurant
JP3908444B2 (ja) * 2000-07-31 2007-04-25 花王株式会社 糖誘導体の製造法
US6726920B1 (en) 2000-09-22 2004-04-27 Durect Corporation Implantable drug delivery patch
US6444466B1 (en) 2001-05-10 2002-09-03 Isis Pharmaceuticals, Inc. Antisense modulation of helicase-moi expression
US7407943B2 (en) 2001-08-01 2008-08-05 Isis Pharmaceuticals, Inc. Antisense modulation of apolipoprotein B expression
US6824599B2 (en) 2001-10-03 2004-11-30 The University Of Alabama Dissolution and processing of cellulose using ionic liquids
US20050070500A1 (en) 2001-12-13 2005-03-31 Boucher L Isabelle Method of modulating release of saccharides and uses thereof
CA2507846A1 (en) 2001-12-14 2003-06-26 Ism Biopolymer Inc. Chitosan oligosaccharides and uses thereof
US20040138119A1 (en) 2002-09-18 2004-07-15 Ingo Tamm Use of hepatitis B X-interacting protein (HBXIP) in modulation of apoptosis
US20060058261A1 (en) 2004-09-15 2006-03-16 Andre Aube Chitin derivatives for hyperlipidemia
US7282194B2 (en) 2004-10-05 2007-10-16 Gp Medical, Inc. Nanoparticles for protein drug delivery
US7381716B2 (en) 2005-11-21 2008-06-03 Gp Medical, Inc. Nanoparticles for protein drug delivery
US7291598B2 (en) 2005-01-04 2007-11-06 Gp Medical, Inc. Nanoparticles for protein drug delivery
JP2009511435A (ja) 2005-09-28 2009-03-19 ディーエヌピー・カナダ・インコーポレーテッド 高脂血症の予防および治療のためのポリキトサミンとフィブレートの組み合わせ
BRPI0619999A2 (pt) 2005-12-16 2011-10-25 Dnp Canada Inc derivados de quitina para hiperlipidemia
WO2008067573A2 (en) * 2006-12-01 2008-06-05 Tshwane University Of Technology Drug delivery system
JP5301237B2 (ja) * 2007-10-17 2013-09-25 新日鉄住金化学株式会社 可溶化リグニン、糖類原料および単糖類原料の製造方法
CN101157735B (zh) * 2007-11-27 2010-09-08 江南大学 一种n,n,n-三甲基壳聚糖硫酸甲酯铵的合成方法
JP2010242020A (ja) * 2009-04-09 2010-10-28 Kazuyuki Umemura 脱ｎ−アセチル体の製造方法
EP2718331B1 (en) * 2011-06-13 2017-08-02 Rival S.E.C N,n,n-trialkylpolymers, methods of their preparation and uses thereof

Also Published As

Publication number Publication date
JP2017222869A (ja) 2017-12-21
EP2718331A4 (en) 2015-04-15
EP2718331A1 (en) 2014-04-16
EP2718331B1 (en) 2017-08-02
US20140107329A1 (en) 2014-04-17
WO2012171125A1 (en) 2012-12-20
JP6346561B2 (ja) 2018-06-20
JP2014518289A (ja) 2014-07-28
US9505852B2 (en) 2016-11-29
CA2869821C (en) 2018-06-19
CA2869821A1 (en) 2012-12-20

Similar Documents

Publication Publication Date Title
ES2644138T3 (es) N,N,N-trialquilpolímeros, métodos para su preparación y usos de los mismos
Kim Chitin and chitosan derivatives: advances in drug discovery and developments
Avadi et al. Diethylmethyl chitosan as an antimicrobial agent: Synthesis, characterization and antibacterial effects
Bakshi et al. Comparative study on antimicrobial activity and biocompatibility of N-selective chitosan derivatives
Prashanth et al. Free radical-induced chitosan depolymerized products protect calf thymus DNA from oxidative damage
Anna et al. Pharmacological and biological effects of chitosan
ES2725874T3 (es) Derivados obtenidos a partir de ácido hialurónico y carnosina
WO2017177342A1 (en) Anti-infective compositions comprising phytoglycogen nanoparticles
CN120360971A (zh) 一种治疗幽门螺旋杆菌感染的口溶膜剂及其制备方法
JPH08253503A (ja) キトオリゴ糖の部分ｎ−アシル化体又はその塩
US20100183724A1 (en) Hydrogel of Chitosan Carboxyalkylamide, Preparation Thereof and Cosmetic and Dermatological Use Thereof
WO2018138221A1 (en) Hyaluronic acid cross-linked with natural or semi-synthetic crosslinking agents
Younessi et al. Preparation and ex vivo evaluation of TEC as an absorption enhancer for poorly absorbable compounds in colon specific drug delivery
JP2003048839A (ja) 免疫反応性ＮＯ合成を誘導するｉＮＯＳ酵素を刺激する組成剤およびその製造方法
WO1997041894A1 (fr) Composition aqueuse micellaire et procede de solubilisation d'un medicament hydrophobe
CN101039963B (zh) 生物素化十六糖，它们的制备方法及其用途
US20100093661A1 (en) Composition comprising chitosan and an acidic drug for oral controlled release
EP1921091B1 (en) Process for the preparation of esters of the diacerein with hyaluronic acid and pharmaceutical preparations containing them
Ponomarev et al. Synthesis of water-soluble chitosan derivatives and their use for the stabilization of liposomal suspensions
EP3494990A1 (en) Immunostimulator, pharmaceutical composition, and food or beverage
JP3574719B2 (ja) キトサン誘導体と、そのキトサン誘導体を含有する化粧料
Manikiran et al. Formulation Perspectives of Chitosan: A Biomolecule for Microencapsulation
Tiew Hydrophobically modified low molecular weight chitosan for drug delivery/Tiew Shu Xian
Wang et al. Effect of dietary carboxymethyl chitosans on the levels of iron, zinc and copper in mice
Xian Hydrophobically Modified Low Molecular Weight Chitosan for Drug Delivery